Europe Human Fibrin Glue Market, By Packaging Form (Liquid, Patch, Others), Application (Cardiac Surgery, Pulmonary Surgery, Burn Bleeding, Vascular Surgeries, Orthopedic Surgeries, Lacerations of liver and Spleen, Neurosurgery, Plastic Surgery, General Surgery, Wound Management, others), Distribution Channel (Direct Tender and Retail Sales), End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Others), Country (Germany, France, U.K., Italy, Spain, Russia, Netherland, Switzerland, Turkey, Austria, Belgium, Rest of Europe) Industry Trends and Forecast to 2029.
Europe human fibrin glue market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.0% in the forecast period of 2022 to 2029, and is expected to reach USD 214.04 million by 2029. Increase in products development and rising demand for early diagnosis are the major drivers which propelled the demand of the market in the forecast period. However the stringent regulatory is hindering the market growth.
Human fibrin glues are involved in the process of hemostasis and wound healing. A Human Fibrin Glue (HFG) is made of two components contained in separate vials: a freeze-dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant), and freeze-dried thrombin (the catalyst), which is applied to a wound or during the surgery to avoid blood loss, create a clot for hemostasis, decrease the hospital stay with lesser scars.
The rise in FDA approval and the presence of major market players are projected to increase the market growth. The rising government investments and awareness among the population allow the market to enhance the treatment. However, the increasing product recall is projected to challenge the market.
The human fibrin glue market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.
Human fibrin glue market is categorized into four notable segments, based on package form, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of package form, the human fibrin glue market is segmented into liquid, patch, and others. In 2022, liquid segment is expected to dominate the Europe human fibrin glue market, due to increase in government spending on healthcare.
- On the basis of application, the human fibrin glue market is segmented into cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery, general surgery, wound management, and others. In 2022, wound management segment is expected to dominate the Europe human fibrin glue market, with the increasing surgical procedures in this region.
- On the basis of end user, the human fibrin glue market is segmented into hospitals, ambulatory care centre, specialty clinics, and others. In 2022, hospital segment is expected to dominate the market, due to growing demand of human fibrin glues.
- On the basis of distribution channel, the human fibrin glue market is segmented into direct tender and retail sales. In 2022, direct tender segment is expected to human fibrin glues market, with the presence of major market players.
Human Fibrin Glue Market Country Level Analysis
The human fibrin glue market is analyzed and market size information is provided on the basis of package form, application, end user and distribution channel.
The countries covered in the human fibrin glue market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, and Rest of Europe.
Germany is expected to dominate the Europe human fibrin glue market, due to growth of R & D in healthcare industry.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure are Boosting the Market Growth of Human Fibrin Glue
Human fibrin glue market also provides you with detailed market analysis for every country growth in Human fibrin glue industry with human fibrin glue sales, impact of advancement in the human fibrin glue technology and changes in regulatory scenarios with their support for the human fibrin glue market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Human Fibrin Glue Market Share Analysis
Human fibrin glue market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to human fibrin glue market.
Some of the major companies dealing in the Europe human fibrin glue market are Johnson & Johnson Services, Inc., Baxter, CSL Limited and Corza Health. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the human fibrin glue market.
- In February 2021, Corza Health acquired and merged Surgical Specialties Corporation (“Surgical Specialties”) and the TachoSil Fibrin Sealant Patch (“TachoSil”) to create a new company, Corza Medical. This merger have increased company’s product portfolio and sales.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the human fibrin glue market which also provides the benefit for organization to improve their offering for human fibrin glue.
Customization Available: Europe Human Fibrin Glue Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.